2026 DDI Multidisciplinary – General Session

Day 1- Multidisciplinary Session
November 9, 2026

Monday
Start Time	End Time	Session	Topic	Facilitator	Faculty Presenting	Faculty Hospital
7:30 AM	8:00 AM		Registration / Breakfast
8:00 AM	8:10 AM	Session 1: Colorectal Cancer: From Early Detection to Locoregional Intervention	Advanced endoscopic resection of large colorectal polyps: ESD, piecemeal EMR, and when to operate	Kevin El-Hayek, MD MBA & Resmi Charalel, MD MPH FSIR	Mohamed Tausif Siddiqui, MD	Cleveland Clinic
8:10 AM	8:20 AM		Minimally invasive colectomy and transanal approaches: oncologic outcomes and evolving indications		Daniel Popowich, MD	Northwell Health
8:20 AM	8:30 AM		Surgical Strategies for CRLM: Parenchymal-Sparing Hepatectomy, Two-Stage Resection, and Conversion Pathways		Martin Dib, MD	Beth Israel Deaconess Medical Center
8:30 AM	8:40 AM		Thermal Ablation for CRLM: Image-Guided Precision Therapy, Margin Optimization, and Combination Treatment Strategies		Raul Uppot, MD	Mass General Brigham
8:40 AM	8:50 AM		Hepatic Arterial Infusion Therapy in CRLM: Expanding Curative-Intent Options Beyond Systemic Therapy Alone		Sophia McKinley, MD EdM	Massachusetts General Hospital
8:50 AM	9:00 AM		Hepatic Augmentation: Planning for surgical resection		Resmi Charalel, MD MPH FSIR	Montefiore Einstein
9:00 AM	9:10 AM		Systemic Therapy in Metastatic Colorectal Cancer: Perioperative Sequencing, Biologic Selection, and Evolving Combination Strategies		Thomas Abrahms, MD	Dana-Farber Cancer Institute
9:10 AM	9:40 AM	Session 2: Multidisciplinary Tumor Board I- CRLM	Multidisciplinary Tumor Board – CRLM. 2-3 Cases (Include Panel discussion: the patient with a large rectal lesion and synchronous liver metastases)	Resmi Charalel, MD MPH FSIR & Daniel Chang, MD	Resmi Charalel, MD MPH FSIR	Montefiore Einstein
					Daniel Chang, MD	University of Michigan
					Daniel Popowich, MD	Northwell Health
					Aparna Parikh, MD	Mass General Brigham
9:40 AM	10:00 AM		Break and Vendor Visiting in Exhibit Lounge
10:00 AM	10:10 AM	Session 3: Biliary Stricture: Benign and Malignant — Diagnosis to Definitive Management	Indeterminate biliary strictures: cholangioscopy, FISH, and next-gen cytology & stenting	Charles Kim, MD & Ashley Faulx, MD	Kunal Jajoo, MD	Brigham and Women’s Hospital
10:10 AM	10:20 AM		Percutaneous transhepatic cholangiography and biliary intervention for failed or inaccessible ERCP		Shams Iqbal, MD FSIR	Massachusetts General Hospital
10:20 AM	10:30 AM		Endoscopic stenting for benign biliary strictures: current evidence		Aleksey Novikov, MD	Massachusetts General Hospital
10:30 AM	10:40 AM		IR Benign biliary stricture protocols – what works best?		Robert Liddell, MD	Johns Hopkins School of Medicine
10:40 AM	10:50 AM		Advances in IR management of benign biliary strictures		Ahsun Riaz, MD	Northwestern University
10:50 AM	11:00 AM		Endoscopic techniques to reach the biliary tree in patients with altered duodenal anatomy		Kumar Krishnan, MD	Massachusetts General Hospital
11:00 AM	11:10 AM		IR Cholangioscopic characterization of biliary strictures		Alex Newbury, MD	University of Massachusetts Chan Medical School
11:10 AM	11:20 AM		Management of postoperative biliary leaks		Jeff Weinstein, MD	Harvard
11:20 AM	11:40 AM	Session 4	Debate presentations: Best approach for management of biliary obstruction due to Klatskin tumors	Kevin El-Hayek, MD, MBA, FACS & Ron Arellano, MD	Ashley Faulx, MD	University Hospitals Cleveland Medical Center
					Ann Covey, MD FSIR	Memorial Sloan Kettering Cancer Center
					Sophia McKinley, MD EdM	Massachusetts General Hospital
11:40 AM	12:40 PM	Hands on Workshop/Lunch	Liver Ablation	Boston Scientific	Shane Wells, MD	U of Michigan
					Raul Uppot, MD	Mass General Brigham
12:40 PM	12:48 PM	Session 5: Pancreaticobiliary Interventions	Non-lithotripsy indications for transhepatic cholangioscopy	Anne Covey, MD & Harjit Singh, MD	Sidhartha Tavri, MD	Oregon Health and Science University
12:48 PM	12:56 PM		Endoscopic management and advances for malignant biliary strictures		Jaehoon Cho, MD	Columbia
12:56 PM	1:04 PM		Occluded bile duct: Percutaneous recanalization		Ahsun Riaz, MD	Northwestern University
1:04 PM	1:12 PM		Endoscopic solutions for gallstone cholecystitis for nonsurgical candidates		Ashley Faulx, MD	Case Western Reserve University School of Medicine
1:12 PM	1:20 PM		Percutaneous Lithotripsy of gallstones		Alex Jacobson, MD	BWH
1:20 PM	1:28 PM		IR solutions for gallstone resolution for nonsurgical candidates: Cryoablation		Eric Mastria, MD	Duke University
1:28 PM	1:36 PM		Celiac plexus denervation for glucose control in diabetes		Thomas An, MD	Massachusetts General / Brigham Hospitals
1:36 PM	1:44 PM		Pancreatic duct obstruction – Are there any percutaneous options?		Charles Kim, MD	Duke University
1:44 PM	1:52 PM		Pancreatic duct obstruction – Endoscopic approach		Linda Lee, MD	Brigham
1:52 PM	2:00 PM	Session 6: Portal Hypertension	Portal Hypertension Roadmap: Baveno VII, AASLD 2024, EASL 2025 and When to Call IR (CSPH definitions, recompensation, NILDA/NIT thresholds, urgent versus elective referral triggers, and the minimum data IR should request before accepting a consult)	Sameer Gadani, MD & Baljendra Kapoor, MD	Sameer Gadani, MD	Cleveland Clinic
2:00 PM	2:08 PM		Endoscopic management of esophageal and gastric varices: strengths and limitations (Strengths and limitations of endoscopic management with data)		Marvin Ryou, MD	Harvard
2:08 PM	2:16 PM		Who Should Not Get TIPS Today? Pre-TIPS Optimization and Risk Modeling (MELD-Na/MELD 3.0, FIPS, bilirubin, creatinine, sodium, sarcopenia/frailty, baseline HE, cardiac/pulmonary workup, ACLF and transplant window)		Paula Novelli, MD	UPM
2:16 PM	2:24 PM		Acute Variceal Bleeding in 2026: Rescue vs Pre-emptive TIPS, Including Fundal Gastric Varices (High-risk EV/GOV bleeding, fundal GV GAVAPROSEC data, timing within 72 hours, severe alcohol-related hepatitis, glue/NSBB interface and when RTO is preferred)		Wael Saad, MD	University of Utah Health
2:24 PM	2:32 PM		Early or elective TIPS for Ascites, Hydrothorax, HRS Physiology Interventional Radiology Recurrent/refractory ascites, hydrothorax, renal/cardiac tradeoffs		Pilar Bayona Molano, MD
2:32 PM	2:40 PM		TIPS in 2026: Controlled-Expansion Stents, Under dilation and PSG Goals Interventional Radiology Stent-graft choice, 6/8/10 mm strategy, controlled expansion, underdilation, target gradient by indication, variceal embolization and HE minimization.		Jacob Cynamon, MD	Montefiore Einstein
2:40 PM	2:48 PM		Medical and Interventional Radiology Management of HE after TIPS Interventional Radiology Discuss risk factors of HE and how to manage after TIPS		Tina Sankhla, MD	Emory
2:48 PM	2:56 PM		Difficult-Access TIPS: Transsplenic, Transhepatic, Transmesenteric, Gun-sight and DIPS Escalation Interventional Radiology When to escalate, how to close access tracts, bleeding avoidance, intravascular snaring, Rosch-Uchida/Colapinto nuances, pediatric/LDLT variants.		Khashayar Farsad, MD PhD	OHSU
2:56 PM	3:04 PM		Post-TIPS liver failure: predictors, prevention and salvage strategies Interventional Radiology (Post-TIPS liver failure predictors, stenosis/thrombosis revision, shunt reduction/occlusion, ACLF, M&M pearls and transplant bridge).		Vijay Ramalingam, MD	Beth Israel Deaconess Medical Center
3:04 PM	3:12 PM		Splenic Inflow Modulation: is it an adjunct or alternative of TIPS Interventional Radiology Refractory ascites when TIPS is contraindicated, hypersplenism, splenic steal/portal hyperperfusion after LT, embolization endpoints, complications and prophylaxis.		Kei Yamada, MD	Tufts
3:12 PM	3:20 PM		Evolving indications of TIPS		Baljendra Kapoor, MD	University of Michigan
3:20 PM	3:30 PM		Break and Vendor Visiting in Exhibit Lounge
3:30 PM	3:38 PM	Session 7: Technical Considerations: Master Class- a case-based approach	Portal vein recanalization-Master class: technical considerations.	Dan Patel, MD & Nicholas Befera, MD	Sameer Gadani, MD	Cleveland Clinic
3:38 PM	3:46 PM		Beyond TIPS: Percutaneous splenorenal and other porto-mesenteric shunts-Technical Considerations		Paul Suhocki, MD	Duke University
3:46 PM	3:54 PM		Gastrointestinal/Variceal Hemorrhage-Evolution of Embolic agents: Technical considerations		Yan Epelboym, MD MPH	Mass General Brigham
3:54 PM	4:02 PM		Percutaneous Hepatic Perfusion		Eric Wehrenberg-Klee, MD	Massachusetts General Hospital
4:02 PM	4:10 PM		Microbot Angio Robot Device-Clinical applications		Dmitry Rabkin, MD	Mass General Brigham
4:10 PM	4:18 PM	Session 8: Visceral Trauma	Hepatobiliary trauma	Jon Lorenz, MD & Steve Zangan, MD	Steve Zangan, MD	University of Chicago
4:18 PM	4:26 PM		Splenic and Pancreatic injuries		David Johnson, MD	Duke University
4:26 PM	4:34 PM		Visceral artery pseudoaneurysms		Mohammed Bader, MD	Boston Medical Center
4:34 PM	4:42 PM		Intraabdominal venous injuries		Matt Abad-Santos, MD	USC Keck School of Medicine
4:42 PM	4:50 PM		Liquid embolic agents in trauma-Case based review		James Jeffries, MD	The University of Washington School of Medicine
4:50 PM	5:00 PM		Discussion: Trauma Response in IR		Jon Lorenz, MD	University of Chicago
5:30 PM	6:30 PM	Hands on Workshop/Social Hour	Cholangioscopy for IR	Boston Scientific	Alexander Vezeridis, MD	Stanford
					Ravi Srinivasa, MD FSIR	UCLA

Day 2- Multidisciplinary Session
November 10, 2026

Tuesday
Start Time	End Time	Session	Topic	Facilitator	Faculty Presenting	Faculty Hospital
7:30 AM	8:00 AM		Registration / Breakfast
8:00 AM	8:10 AM	Session 9: GI Leaks and Enterocutaneous Fistulae: Multidisciplinary Strategies for Closure and Control	Endoscopic closure of GI leaks and fistulae: over-the-scope clips, endoscopic suturing, and covered stents — patient selection and technique	Michael Terjimanian, MD & Ryan Juza, MD	Ryan Juza, MD	University of Wisconsin
8:10 AM	8:20 AM		IR-guided drainage and fistula management: percutaneous abscess control, fistulography, and tract embolization		Michael Terjimanian, MD	University of Michigan
8:20 AM	8:30 AM		Surgical management of gastrointestinal leaks: timing, source control, nutritional optimization, and definitive repair		Charudutt Paranjape, MD	Mass General Brigham
8:30 AM	8:45 AM		Panel discussion: the post-operative patient with an anastomotic leak, undrained collection, and high-output fistula		Ryan Juza, MD	University of Wisconsin
					Michael Terjimanian, MD	University of Michigan
					Charudutt Paranjape, MD	Mass General Brigham
8:45 AM	8:57 AM	Session 10: Pancreatic Cystic Neoplasms and Low-Grade Malignancies: Diagnosis, Surveillance, and Intervention	EUS-guided diagnosis and risk stratification of pancreatic cystic neoplasms: through-the-needle biopsy, cyst fluid analysis, and emerging molecular markers	Bill Sherk, MD & Kevin El-Hayek, MD, MBA, FACS	Linda Lee, MD	Brigham and Women’s Hospital
8:57 AM	9:09 AM		Endoscopic ablation of pancreatic cysts: EUS-guided ethanol and radiofrequency ablation — evidence and patient selection		Kumar Krishnan, MD	Massachusetts General Hospital
9:09 AM	9:21 AM		Surgical resection of pancreatic cystic neoplasms and low-grade malignancies: minimally invasive pancreatectomy, parenchymal-sparing approaches, and oncologic thresholds		Kevin El-Hayek MD, MBA, FACS	The MetroHealth System
9:21 AM	9:33 AM		IR management of post-pancreatectomy complications: Vascular		Bill Sherk, MD	University of Michigan
9:33 AM	9:45 AM		IR management of post-pancreatectomy complications: Non-Vascular		Keith Quencer, MD	OHSU
9:45 AM	10:00 AM		Panel discussion: the patient with a symptomatic 4 cm branch-duct IPMN and worrisome features		Ashley Faulx, MD	University Hospitals Cleveland Medical Center
					Kumar Krishnan, MD	Massachusetts General Hospital
					Kevin El-Hayek MD, MBA, FACS	The MetroHealth System
					Bill Sherk, MD	University of Michigan
10:00 AM	10:20 AM		Break and Vendor Visiting in Exhibit Lounge
10:20 AM	11:00 AM	Session 11: Keynote Lecture	Advances in Transplant Oncology: Role of Multidisciplinary Patient Centered Care		Shimul Shah, MD	Mass General Brigham
11:00 AM	11:10 AM	Session 12: Hepatocellular Carcinoma (HCC)	Early Hepatocellular Carcinoma in 2026: Expanding Curative Hepatic Resection with Parenchymal-Sparing Strategies, Minimally Invasive Approaches, and Long-Term Oncologic Outcomes	Eric Hoffer, MD & Martin Dib, MD	Martin Dib, MD	Beth Israel Deaconess Medical Center
11:10 AM	11:20 AM		Next-Generation Ablation: Thermal ablation, Histotripsy, Fusion Imaging, and Combination Locoregional Therapy for Early HCC		Paul Shyn, MD	Harvard Medical School, Brigham and Women’s Hospital
11:20 AM	11:30 AM		Liver Transplantation for HCC in the Era of Expanded Criteria: Downstaging, Biology-Based Selection, and Bridging Innovation		Teresa Rice, MD	Mass General Brigham
11:30 AM	11:40 AM		Beyond TACE: Y-90 Radiation Segmentectomy, Personalized Dosimetry, and Systemic Integration in Advanced HCC		Suvranu Ganguli, MD	Boston Medial Center/Boston University School of Medicine
11:40 AM	11:50 AM		The Hepatologist’s Role in Modern HCC Management: Risk Stratification, Liver Function Optimization, and Guiding Curative-Intent Multidisciplinary Therapy		Irun Bhan, MD	Massachusetts General Hospital
11:50 AM	12:00 PM		Noon Immunotherapy Revolution in HCC: IO + VEGF Combinations, Peri-Transplant Considerations, and Emerging Biomarkers		Kelsey Lau-Min, MD	Mass General Brigham Cancer Institute
12:00 PM	1:00 PM	Hands on Workshop & Lunch	Liquid Embolics	Sirtex	Ke Zhang, MD PhD	Brigham and Women’s Hospital
					Suvranu Ganguli, MD	Boston Medial Center/Boston University School of Medicine
1:00 PM	1:45 PM	Session 13: Multidisciplinary Tumor Board II – HCC	Multidisciplinary Tumor Board I – HCC, Curative Intent and Transplant Decision-Making	Kevin Kim, MD & Boris Hristov, MD	Martin Dib, MD	Beth Israel Deaconess Medical Center
					Baljendra Kapoor, MD	University of Michigan
					Paul Shyn, MD	Harvard Medical School, Brigham and Women’s Hospital
					Suvranu Ganguli, MD	Boston Medial Center/Boston University School of Medicine
					Ameer Elaimy, MD PhD	University of Michigan
					Kelsey Lau-Min, MD	Mass General Brigham Cancer Institute
					Nataliya Razumilava, MD	University of Michigan
1:45 PM	1:55 PM	Session 14: Cholangiocarcinoma	Surgery for Cholangiocarcinoma in 2026: Defining Resectability, Complex Hepatectomy, and Curative-Intent Strategy	Manish Varma, MD & Raul Uppot, MD	Manish Varma, MD	Tufts Medical Center, Boston, MA
1:55 PM	2:05 PM		Liver-Directed Therapy for Cholangiocarcinoma: Y-90, Arterial Infusion, and Conversion to Resection Strategies		Neal Viradia, MD	University of Miami/Bruce Carter VA
2:05 PM	2:15 PM		Radiation Therapy in Cholangiocarcinoma: From Definitive Local Control to Neoadjuvant Bridge and Oligoprogression Management		Hannah Roberts, MD	Mass General Brigham
2:15 PM	2:25 PM		Precision Oncology in Cholangiocarcinoma: Targeted Therapy, Molecular Subtyping, and Clinical Trial-Driven Treatment Selection		Andrea Bullock, MD MPH	Beth Israel Deaconess Medical Center
2:25 PM	3:00 PM	Session 15: Multidisciplinary Tumor Board III – Cholangiocarcinoma	Multidisciplinary Tumor Board II – Cholangiocarcinoma, Complex Biliary Malignancy Management	Charles Kim, MD & Manish Varma, MD	Kumar Krishnan, MD	Massachusetts General Hospital
					Manish Varma, MD	Tufts Medical Center, Boston, MA
					Steve Huang, MD	The University of Texas MD Anderson
					Andrea Bullock, MD MPH	Beth Israel Deaconess Medical Center
					Hannah Roberts, MD	Mass General Brigham
3:00 PM	3:30 PM		Break and Vendor Visiting in Exhibit Lounge
3:30 PM	3:40 PM	Session 16: Neuroendocrine Tumors (NET)	Surgical Cytoreduction for NET Liver Metastases: Defining the Modern Threshold for Aggressive Liver Debulking	John Kachura, MD FSIR & James Frencher, MD	Eduardo Vega, MD	Boston Medical Center
3:40 PM	3:50 PM		Embolotherapy for NET Liver Metastases: Optimizing TAE, TACE, and Y-90 for Durable Disease Control and Symptom Palliation		James Frencher, MD	University of Michigan Medical School
3:50 PM	4:00 PM		PRRT and Systemic Therapy Integration in NETs: Sequencing Theranostics, Somatostatin Analogs, and Targeted Agents for Liver-Dominant Disease		Jennifer Chan, MD	Dana-Farber Cancer Institute
4:00 PM	4:30 PM	Session 17: Multidisciplinary Tumor Board IV – NETs	Multidisciplinary Tumor Board III NETs, Cytoreduction vs Disease Control Strategy	Suvranu Ganguli, MD & Jennifer Chan, MD	Eduardo Vega, MD	Boston Medical Center
					Eric Wehrenberg-Klee, MD	Massachusetts General Hospital
					John Kachura, MD, FSIR	Toronto General Hospital
					Jennifer Chan, MD	Dana-Farber Cancer Institute
					Boris Hristov, MD	University of Michigan
4:30 PM	5:30 PM	Session 18: My Best Save	Case 1	Sid Tavri, MD & Dan Patel, MD	Ajinkya Desai, MD	Massachusetts General Hospital
			Case 2		Alexander Vezeridis, MD	Stanford
			Case 4		Keith Quencer, MD	OHSU
			Case 5		Lauren Ferrara, MD	UMass Chan Medical School
			Case 6		Nick Befera, MD	Duke University
5:30 PM	5:35 PM	Session 19: Best Abstract Award			Resmi Charalel, MD MPH FSIR	Montefiore Einstein